NASDAQ
Aerovate Therapeutics, Inc. (AVTE) has a free cash flow growth of -39.39% as of Friday, May 29, 2026. This represents a 87.88% increase compared to its 12-month average of -325.02%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.